Product image of Gutron (Midodrine Hydrochloride) supplied by GNH India

Gutron

Active Ingredient:
Midodrine Hydrochloride
Origin:
EU

Gutron (Midodrine Hydrochloride)

Gutron is a prescription medication that contains the active ingredient Midodrine Hydrochloride, supplied in an oral dosage form for use in the European Union. It belongs to the alpha‑adrenergic agonist class and is indicated for the management of orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing.

Manufacturer / TM Owner

Cheplapharm Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gutron is prescribed to help patients who experience low blood pressure when moving to an upright position. It is used in clinical practice to improve standing blood pressure and reduce symptoms such as dizziness or fainting.

  • Treatment of orthostatic hypotension in adults
  • Management of symptomatic low standing blood pressure
  • Adjunct therapy when non‑pharmacologic measures are insufficient
  • Support for patients with neurogenic causes of blood pressure drop

Side Effects

Side effects of Gutron can vary in frequency and severity. Common reactions are usually mild, while serious events are less frequent but require medical attention.

Common

  • Piloerection (goosebumps)
  • Pruritus (itching)
  • Urinary urgency or frequency
  • Scalp tingling or flushing
  • Supine hypertension (elevated blood pressure while lying down)

Serious

  • Severe supine hypertension leading to cardiovascular risk
  • Allergic reactions such as rash or angioedema
  • Chest pain or palpitations
  • Persistent headache

Precautions & Warnings

Before starting Gutron, certain health considerations should be reviewed to ensure safe use. Patients and clinicians should be aware of the following precautions:

  • Assess for existing hypertension, especially supine hypertension
  • Evaluate renal or hepatic impairment, which may affect drug metabolism
  • Review cardiovascular history, including heart failure or arrhythmias
  • Caution in patients with urinary retention or bladder outlet obstruction
  • Discuss pregnancy and lactation status, as safety data are limited
  • Monitor blood pressure regularly after dose adjustments

Avoid Interactions

Gutron may interact with other medications, influencing its effectiveness or increasing the risk of adverse effects. Interaction guidance includes:

Avoid

  • Other vasoconstrictors or sympathomimetic agents that may exacerbate hypertension
  • Monoamine oxidase inhibitors (MAOIs) taken within 14 days of Gutron
  • Direct-acting alpha‑agonists such as phenylephrine

Use with caution

  • Antihypertensive drugs (e.g., ACE inhibitors, beta‑blockers) that could lower blood pressure excessively
  • Diuretics, which may affect fluid balance and blood pressure
  • Central nervous system depressants that may mask symptoms of hypotension

Frequently Asked Questions

Gutron contains Midodrine Hydrochloride, a prodrug that is converted to an active metabolite stimulating peripheral alpha‑1 adrenergic receptors, causing vasoconstriction and raising standing blood pressure.

Gutron is primarily prescribed for orthostatic hypotension, a disorder characterized by a significant drop in blood pressure upon standing.

Gutron is taken orally in tablet form, as directed by a healthcare professional.

Patients with hypertension, especially supine hypertension, should be evaluated carefully before using Gutron, and blood pressure should be monitored regularly.

Common side effects include goosebumps, itching, urinary urgency, scalp tingling, flushing, and mild supine hypertension.

Serious reactions such as severe supine hypertension, allergic rash or angioedema, chest pain, palpitations, or persistent headache should be evaluated promptly.

Gutron may interact with antihypertensive drugs; dosage adjustments and close monitoring are recommended when used together.

Safety data for Gutron during pregnancy and lactation are limited; it should only be used if the potential benefit justifies the potential risk and after consulting a healthcare provider.

Patients should avoid other vasoconstrictors, sympathomimetic agents, MAO inhibitors taken within 14 days, and direct‑acting alpha‑agonists such as phenylephrine.

Blood pressure should be checked regularly, especially after dose changes, to ensure adequate control of orthostatic hypotension without causing supine hypertension.

Renal or hepatic impairment may affect the metabolism of Midodrine; dosage adjustments and careful monitoring are advised.

If a dose is missed, take it as soon as remembered unless it is close to the time of the next scheduled dose; do not double the dose. Follow the prescribing clinician’s instructions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midodrine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT